1. Signaling Pathways
  2. Protein Tyrosine Kinase/RTK
  3. FGFR
  4. FGFR Inhibitors

FGFR Inhibitors

FGFR

FGFR1

FGFR2

FGFR3

FGFR4

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

FGFR Inhibitors
Product Name FGFR FGFR1 FGFR2 FGFR3 FGFR4 Purity
Lenvatinib  
FGFR1, IC50: 46 nM
      99.74%
Nintedanib  
FGFR1, IC50: 69 nM
FGFR2, IC50: 37 nM
FGFR3, IC50: 108 nM
  99.97%
Infigratinib  
FGFR1, IC50: 0.9 nM
FGFR2, IC50: 1.4 nM
FGFR3, IC50: 1 nM
FGFR4, IC50: 60 nM
99.16%
AZD4547  
FGFR1, IC50: 0.2 nM
FGFR2, IC50: 2.5 nM
FGFR3, IC50: 1.8 nM
FGFR4, IC50: 165 nM
99.80%
ASP5878  
FGFR1, IC50: 0.47 nM
FGFR2, IC50: 0.6 nM
FGFR3, IC50: 0.74 nM
FGFR4, IC50: 3.5 nM
99.71%
CP-547632 hydrochloride
FGFR, IC50: 9 nM
       
Lenvatinib mesylate  
FGFR1, IC50: 46 nM
     
PD173074  
FGFR1, IC50: 25 nM
      99.55%
SU 5402  
FGFR1, IC50: 30 nM
      99.39%
Roblitinib        
FGFR4, IC50: 1.9 nM
98.08%
Rogaratinib  
FGFR1
FGFR2
FGFR3
FGFR4
99.38%
Lucitanib  
FGFR1, IC50: 17.5 nM
FGFR2, IC50: 82.5 nM
    98.24%
LY2874455  
FGFR1, IC50: 2.8 nM
FGFR2, IC50: 2.6 nM
FGFR3, IC50: 6.4 nM
FGFR4, IC50: 6 nM
98.02%
Gandotinib    
FGFR2, IC50: 32 nM
FGFR3, IC50: 106 nM
  99.96%
Nintedanib esylate  
FGFR1, IC50: 69 nM
FGFR2, IC50: 37 nM
FGFR3, IC50: 108 nM
  99.95%
Futibatinib
FGFR
        98.80%
Fisogatinib        
FGFR4
99.84%
KW-2449  
FGFR1, IC50: 36 nM
      99.85%
PRN1371  
FGFR1, IC50: 0.6 nM
FGFR2, IC50: 1.3 nM
FGFR3, IC50: 4.1 nM
FGFR4, IC50: 19.3 nM
99.24%
CH5183284  
FGFR1, IC50: 9.3 nM
FGFR2, IC50: 7.6 nM
FGFR3, IC50: 22 nM
FGFR4, IC50: 290 nM
99.73%
Dovitinib lactate      
FGFR3, IC50: 5 nM
  99.77%
Pazopanib Hydrochloride  
FGFR1, IC50: 140 nM
      99.83%
PD-166866  
FGFR1, IC50: 52.4 nM
      99.97%
Derazantinib  
FGFR1, IC50: 4.5 nM
FGFR2, IC50: 1.8 nM
FGFR3, IC50: 4.5 nM
  99.06%
FIIN-2  
FGFR1, IC50: 3.1 nM
FGFR2, IC50: 4.3 nM
FGFR3, IC50: 27 nM
FGFR4, IC50: 45 nM
99.95%
Sulfatinib  
FGFR1
      97.97%
S49076  
FGFR1, IC50: 18 nM
FGFR1V561M, IC50: 23 nM
FGFR2, IC50: 17 nM
FGFR2N549H, IC50: 19 nM
FGFR3, IC50: 15 nM
  98.99%
Orantinib  
FGFR1, Ki: 1.2 μM
      99.02%
Alofanib    
FGFR2
    99.83%
SSR128129E  
FGFR1, IC50: 1.9 μM
      99.65%
ACTB-1003  
FGFR1, IC50: 6 nM
      97.65%
CP-547632
FGFR, IC50: 9 nM
        >99.0%
Infigratinib phosphate  
FGFR1, IC50: 0.9 nM
FGFR2, IC50: 1.4 nM
FGFR3, IC50: 1 nM
FGFR4, IC50: 60 nM
97.74%
FIIN-3  
FGFR1, IC50: 13.1 nM
FGFR2, IC50: 21 nM
FGFR3, IC50: 31.4 nM
FGFR4, IC50: 35.3 nM
98.13%
FGFR4-IN-1        
FGFR4, IC50: 0.7 nM
99.88%
Tyrosine kinase-IN-1  
FGFR1, IC50: 2 nM
      99.47%
ODM-203  
FGFR1, IC50: 11 nM
FGFR2, IC50: 16 nM
FGFR3, IC50: 6 nM
FGFR4, IC50: 35 nM
SKLB610  
FGFR1
      98.96%
SSR128129E free acid  
FGFR1, IC50: 1.9 μM